Dacomitinib (Vizimpro)

dacomitinib · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dacomitinib (Vizimpro), covering 2014-10-03 to 2014-10-03. Get the full timeline:

Most recent: Clinical Trial Update: Dacomitinib (PF-00299804) Pharmacokinetics In Chinese Healthy Volunteers [Phase 1]